Ridge Diagnostics - Menu
    Ridge Diagnostics MDDScore Depression Blood Test
Facebook Blog Twitter YouTube Linked In    
Home Company Technology & Clinical Studies Healthcare Professional Consumer/Patient News Investor Relations Contact
Patients ask [for diagnostic blood test] all the time, ‘Is there a blood test for this?’ All the time.  Every day.  There’s a big interest. - Psychiatris
Latest News
Latest News January 2014: KPBS Broadcast & Radio News: La Jolla Biotech´s Blood Test Could Help Doctors Diagnose Depression

Latest News
First-In-Class Blood Test for Major Depressive Disorder Events

What Doctors are saying About Ridge Diagnostics

 "As a practicing psychiatrist I believe that the MDDScore™ blood test will have a significant effect on the psychiatric industry. Currently, one of our greatest challenges in the field of psychiatry is the absence of objective tests to help us with the diagnosis of this disorder. " (Psychiatrist)

 "A Psychiatrist´s diagnosis for major depressive disorder is usually based on a series of clinical questions, and clinical assessments, which may cause patients difficulty in validating their disorder. " (Psychiatrist)

A Snap-Shot of The Company

Ridge Diagnostics is a neurodiagnostic company offering its proprietary first-in-class blood test for Major Depressive Disorder (MDD) through its CLIA certified laboratory in North Carolina.  Based upon its proprietary Human Biomarker Library and its Biomarker Hyper-Map™ technology platform, Ridge Diagnostics has developed multi-variant biological marker assays and diagnostic algorithms to diagnose, select and monitor treatment for MDD and other neuropsychiatric disorders.

Antidepressant drugs are the most frequently prescribed medication in the US today where depression strikes over 19 million adults each year – more than coronary artery disease, cancer or AIDS.  For the first time, objective biological test information about depression may aid physicians in the differential diagnosis of MDD, the selection of proper treatment and effective management of their patients.

Events 2013
Ridge Diagnostics presents poster entitled “Serum Biomarker Panel Expression in Adolescent and Young Adult MDD Patients and Healthy Non-Depressed Subjects”
Annual U.S. Psychiatric and Mental Health Congress
September 30 - October 3, 2013
Las Vegas, Nevada

Ridge Diagnostics Presents Data on the Use of a Biomarker Panel for the Detection of Major Depressive Disorder in Centralized Intractable Pain at PAINWeek®
September 4-7, 2013
Las Vegas, Nevada

Ridge Diagnostics, Inc. announces MDDScore™ - First Blood Test for Depression at the American Psychiatric Association Annual Meeting
May 18-21, 2013
San Francisco, CA

Ridge Diagnostics, Inc. Presents Clinical Data on Blood Test for Depression at 68th Annual Scientific Convention and Meeting of the Society of Biological Psychiatry
May 16-18, 2013
San Francisco, CA

Ridge Diagnostics, Inc. CEO spoke at The 6th Annual OneMedForum
January 7-9, 2013
San Francisco, CA

Ridge Diagnostics´ poster “A Multi-Analyte Biomarker Approach for the Detection of Depression in a Clinical Population with Comorbid Pain” won second place at the recent Neuroscience Education Institute´s Congress. The associated abstract was featured in CNS Spectrums┬«.
December 2012

U.S. Psychiatric and Mental Health Congress
November 8-11, 2012
San Diego, CA

NEI Global Psychopharmacology Congress
October 18-21, 2012
San Diego, CA

NCDEU Annual Meeting
May 29-June 1, 2012
Phoenix, AZ

American College of Neuropsychopharmacology
50th Annual Meeting
December 4-8, 2011
Waikaloa Beach, Hawaii

House Oversight and Government Reform Subcommittee on TARP and Financial Services
November 7, 2011
Washington, DC

Privacy Policy